Author(s): Behnaz Bakhshinejad, Mahdiyeh Khazaneha, Mitra Mehrabani, Abdolreza Sabahi, Ali Sadatmoosavi, Oranus Tajedini, Omid Esmaeili, Mehrzad Mehrbani

Email(s): mzmehrbani@yahoo.com

DOI: 10.52711/0974-360X.2024.00047   

Address: Behnaz Bakhshinejad1,2, Mahdiyeh Khazaneha3, Mitra Mehrabani4, Abdolreza Sabahi5, Ali Sadatmoosavi6, Oranus Tajedini7, Omid Esmaeili8, Mehrzad Mehrbani9*
1Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
2Department of Traditional Medicine, Faculty of Persian Medicine, Kerman University of Medical Sciences, Kerman, Iran.
3Department of Scientometrics, Kerman University of Medical Sciences, Kerman, Iran.
4Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran.
5Department of Psychiatry, School of Medicine, Shahid Beheshti Hospital, Kerman University of Medical Sciences, Kerman, Iran.
6Department of Medical Library and Information Sciences, Faculty of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran.
7Department of Knowledge and Information science, Shahid Bahonar University of Kerman, Kerman, Iran.
8School of Medic

Published In:   Volume - 17,      Issue - 1,     Year - 2024


ABSTRACT:
This study aims to draw a science map, provide structural analysis, explore the evolution, and determine new trends in research articles published in the field of obsessive-compulsive disorder (OCD). The articles published from 1981 to 2021 were retrieved by searching the related keywords in multiple databases including PubMed, Scopus, and Web of Science, according to their thematic coverage and scope. The papers were analyzed using R and SciMAT software. A total of 1820 articles were analyzed and 4191 keywords plus, and 3242 author keywords were reported in the journals. Moreover, 7482 authors contributed in conducting these studies, of which 111 articles were written by single authors, and the collaborative coefficient was 4.36. Neuropsychopharmacology, International Clinical Psychopharmacology, and Journal of Clinical Psychopharmacology are the most significant journals publishing OCD articles. This study uncovered new insights into the evolution trend of the leading research stream on OCD over the past years. The findings of this study can contribute to developing the OCD Global Research Program and policymakers.


Cite this article:
Behnaz Bakhshinejad, Mahdiyeh Khazaneha, Mitra Mehrabani, Abdolreza Sabahi, Ali Sadatmoosavi, Oranus Tajedini, Omid Esmaeili, Mehrzad Mehrbani. Dynamic Tracking to Identify Topics and Thematic Evolution of Obsessive-compulsive disorder as an Emerging Topic. Research Journal of Pharmacy and Technology. 2024; 17(1):303-8. doi: 10.52711/0974-360X.2024.00047

Cite(Electronic):
Behnaz Bakhshinejad, Mahdiyeh Khazaneha, Mitra Mehrabani, Abdolreza Sabahi, Ali Sadatmoosavi, Oranus Tajedini, Omid Esmaeili, Mehrzad Mehrbani. Dynamic Tracking to Identify Topics and Thematic Evolution of Obsessive-compulsive disorder as an Emerging Topic. Research Journal of Pharmacy and Technology. 2024; 17(1):303-8. doi: 10.52711/0974-360X.2024.00047   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-1-47


REFERENCES:
1.    Gaikwad U. Parle M. Treatment for the management of Obsessive-Compulsive Disorder in Children: A Review. Research J. Pharm. and Tech. 2010; 3(1): 66-68.
2.    Azarpendar M, Khalighi Z, Bahmani M, Abbasi N, Saki K. Identification of Plant Flora Affecting Common Psychiatric Disorders Based on Ethnobotanical Knowledge of Ilam, Iran. Journal title 2022; 4 (2):57-63. doi: 10.52547/pbp.4.2.7
3.    Jahanshir Tavakolizadeh, Somayeh Safarzade. The Prevalence of Obsessive-Compulsive Disorder in the Population of 18-66-Year-Old City of Gonabad-Iran in 2016. Research J. Pharm. and Tech. 2018; 11(10): 4222-4228.
4.    Leydesdorff L, Milojević S. Scientometrics. arXiv preprint arXiv:12084566. 2012.
5.    Suganya M, Sibikar Prabakar, US Mahadeva Rao. Cognitive Behavioural Therapy in Children and Adolescents. Research Journal of Pharmacy and Technology. 2022; 15(3):1330-6.
6.    Cobo MJ, López‐Herrera AG, Herrera‐Viedma E, Herrera F. SciMAT: A new science mapping analysis software tool. J Am Soc Inf Sci Technol. 2012;63(8):1609-30.
7.    Aria M, Cuccurullo C. bibliometrix : An R-tool for comprehensive science mapping analysis. Journal of Informetrics. 2017; 11(4): 959-75. doi:10.1016/j.joi.2017.08.007.
8.    Cederlöf M, Lichtenstein P, Larsson H, Boman M, Rück C, Landén M, et al. Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study. Schizophr Bull. 2015;41(5):1076-83. doi:10.1093/schbul/sbu169.
9.    Mehraban A, Shams J, Moamenzade S, Samimi SM, Rafiee S, Zademohamadi F. The high prevalence of obsessive-compulsive disorder in patients with chronic pain. Iran J Psychiatry. 2014;9(4):203-8.
10.    Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996; 6(3): 243-50. doi:10.1097/00008571-199606000-00007.
11.    Shifman S, Bronstein M, Sternfeld M, Pisanté-Shalom A, Lev-Lehman E, Weizman A, et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet. 2002; 71(6): 1296-302. doi:10.1086/344514.
12.    Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006; 78(5): 815-26. doi:10.1086/503850.
13.    Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008; 33(2): 368-77. doi:10.1038/sj.npp.1301408.
14.    Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006; 31(11):2384-93. doi:10.1038/sj.npp.1301165.
15.    Reddihough DS, Marraffa C, Mouti A, O’Sullivan M, Lee KJ, Orsini F, et al. Effect of fluoxetine on obsessive-compulsive behaviors in children and adolescents with autism spectrum disorders: a randomized clinical trial. JAMA. 2019; 322(16): 1561-9. doi:10.1001/jama.2019.14685.
16.    Maneeton N, Maneeton B, Karawekpanyawong N, Woottiluk P, Putthisri S, Srisurapanon M. Fluoxetine in acute treatment of children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis. Nord J Psychiatry. 2020; 74(7): 461-9. doi:10.1080/08039488.2020.1744037.
17.    Kotapati VP, Khan AM, Dar S, Begum G, Bachu R, Adnan M, et al. The effectiveness of selective serotonin reuptake inhibitors for treatment of obsessive-compulsive disorder in adolescents and children: a systematic review and meta-analysis. Front Psychiatry. 2019; 10: 523. doi:10.3389/fpsyt.2019.00523.
18.    Staack RF, Maurer HH. Metabolism of designer drugs of abuse. Curr Drug Metab. 2005; 6(3): 259-74. doi:0.2174/1389200054021825.
19.    Gaillard YP, Cuquel AC, Boucher A, Romeuf L, Bevalot F, Prevosto JM, et al. A Fatality Following Ingestion of the Designer Drug Meta‐Chlorophenylpiperazine (mCPP) in an Asthmatic—HPLC‐MS/MS Detection in Biofluids and Hair. J Forensic Sci. 2013;58(1):263-9. doi:10.1111/j.1556-4029.2012.02254.x.
20.    Nardo M, Casarotto PC, Gomes FV, Guimaraes FS. Cannabidiol reverses the mCPP‐induced increase in marble‐burying behavior. Fundam Clin Pharmacol. 2014; 28(5): 544-50. doi:10.1111/fcp.12051.
21.    Bossong MG, Brunt TM, Van Dijk JP, Rigter SM, Hoek J, Goldschmidt HM, et al. mCPP: an undesired addition to the ecstasy market. Journal of Psychopharmacology. 2010; 24(9): 1395-401. doi:10.1177/0269881109102541.
22.    Rivera HM, Santollo J, Nikonova LV, Eckel LA. Estradiol increases the anorexia associated with increased 5-HT(2C) receptor activation in ovariectomized rats. Physiol Behav. 2012; 105(2): 188-94. doi:10.1016/j.physbeh.2011.08.018.
23.    Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George DT, et al. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology. 2011; 36(6): 1178-86. doi:10.1038/npp.2010.253.
24.    Tucci MC, Dvorkin-Gheva A, Graham D, Amodeo S, Cheon P, Kirk A, et al. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive–compulsive disorder (OCD). Psychopharmacology. 2013;227(2):277-85. doi:10.1007/s00213-013-2976-1.
25.    Müller-Vahl K, Szejko N, Wilke F, Jakubovski E, Geworski L, Bengel F, et al. Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder. Sci Rep. 2019; 9(1): 1-10. doi:10.1038/s41598-018-37710-4.
26.    Widomska J, Bralten J, Martens M, De Witte W, van de Vondervoort I, Yu D, et al. Determining the genetic overlap between tourette syndrome (TS), obsessive compulsive disorder (OCD) and OCD/tic-related traits. European Neuropsychopharmacology. 2019; 29: S992-S3. doi:10.1016/j.euroneuro.2017.08.377.
27.    Domínguez AD, Hernández NE, Redondo ML, de la Torre Brasas F, Navarro MO, Díaz LM, et al. Comorbidity of adult ADHD and obsessive-compulsive disorder. European Psychiatry. 2016; 33(S1): S629-S. doi:10.1016/j.eurpsy.2016.01.2362.
28.    Çelebi F, Koyuncu A, Ertekin E, Alyanak B, Tükel R. The features of comorbidity of childhood ADHD in patients with obsessive compulsive disorder. J Atten Disord. 2020; 24(7): 973-80. doi:10.1177/1087054716669228.
29.    Ekinci O, Ekinci AE. Neurological soft signs and clinical features of tic-related obsessive-compulsive disorder indicate a unique subtype. J Nerv Ment Dis. 2020; 208(1): 21-7. doi:10.1097/NMD.0000000000001098.
30.    Briguglio M, Dell’Osso B, Galentino R, Banfi G, Porta M. Higher adherence to the Mediterranean diet is associated with reduced tics and obsessive-compulsive symptoms: A series of nine boys with Obsessive-Compulsive Tic Disorder. Nutrition Clinique et Métabolisme. 2019; 33(3): 227-30. doi:10.1016/j.nupar.2019.04.004.
31.    Murphy T, Storch E, Turner A, Reid J, Tan J, Lewin A. Maternal history of autoimmune disease in children presenting with tics and/or obsessive–compulsive disorder. J Neuroimmunol. 2010; 229(1-2): 243-7. doi:10.1016/j.jneuroim.2010.08.017.
32.    Robakis D. How much do we know about adult-onset primary tics? Prevalence, epidemiology, and clinical features. Tremor Other Hyperkinet Mov (N Y). 2017;7. doi:10.7916/D8SQ95ND.
33.    Conelea CA, Walther MR, Freeman JB, Garcia AM, Sapyta J, Khanna M, et al. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II. J Am Acad Child Adolesc Psychiatry. 2014; 53(12): 1308-16. doi:10.1016/j.jaac.2014.09.014.
34.    Ritter ML, Guo W, Samuels JF, Wang Y, Nestadt PS, Krasnow J, et al. Genome Wide Association Study (GWAS) between Attention Deficit Hyperactivity Disorder (ADHD) and Obsessive Compulsive Disorder (OCD). Front Mol Neurosci. 2017; 10: 83-. doi:10.3389/fnmol.2017.00083. [PubMed:28386217].
35.    Grünblatt E, Oneda B, Ekici AB, Ball J, Geissler J, Uebe S, et al. High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder. BMC Med Genomics. 2017; 10(1): 1-11. doi:10.1186/s12920-017-0299-5.
36.    Shukla T, Nadella RK, Taj MJ RJ, Ganesh S, Nestadt G, Purushottam M, et al. Association of SLC1A1 gene polymorphism with obsessive compulsive disorder in a sample from southern India. Exp Clin Psychopharmacol. 2020;28(6):617. doi:10.1037/pha0000348.
37.    Sunitha P.S , Vidya M, Rashmi P, Mamatha M. Selfy as a Mental Disorder - A Review. Int. J. Adv. Nur. Management. 2016; 4(2): 169-172.
38.    Vijayaraddi Vandali, Rekha Biradar. Selfie Syndrome – A Mental Disorder. Int. J. Nur. Edu. and Research. 2018; 6(3): 287-289.
39.    Chang-Min Son, Bum-Il Min, Hyun-woong Moon. The Effects of Combined Exercise on Blood Lipids and Melatonin in Developmental Disorder Students. Research J. Pharm. and Tech. 2018; 11(12): 5543-5647.
40.    Nandini Prashanth Bhat, Pugazhandhi Bakthavatchalam, Hareesh Krishnan, Ashwija Shetty, Prasanna Lokadolalu Chandracharya. Effect of Ultra-diluted Medicines in Depression and Anxiety: A Narrative Review. Research Journal of Pharmacy and Technology. 2021; 14(9): 5059-4.
41.    Baiq Risky Wahyu Lisnasari, Chrismawan Ardianto, Junaidi Khotib. Microglia as a Potential Target for Antidepressant: A Systematic Review on Preclinical studies. Research Journal of Pharmacy and Technology. 2022;15(7):3317-3.
42.    Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacology and Therapeutics. 2011; 132(3): 314-32. doi:10.1016/j.pharmthera.2011.09.006.
43.    Richter MA, Zai G, McBride JC, Mundo E, Swinson RP, Kennedy JL. The GABA A-Receptor γ2 (GABRG2) Gene in obsessive-compulsive disorder. Braz J Psychiatry. 2009; 31: 328-31. doi:10.1590/s1516-44462009000400008.
44.    Chefer VI, Thompson AC, Zapata A, Shippenberg TS. Overview of brain microdialysis. Curr Protoc Neurosci. 2009; Chapter 7:Unit7.1. doi:10.1002/0471142301.ns0701s47.
45.    Berman NC, Fang A, Hansen N, Wilhelm S. Cognitive-based therapy for OCD: Role of behavior experiments and exposure processes. J Obsessive Compuls Relat Disord. 2015; 6: 158-66. doi:10.1016/j.jocrd.2015.01.001.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available